[
    [
        {
            "time": "",
            "original_text": "复星mRNA新冠疫苗2月下旬抵港，内地上市正加速推进",
            "features": {
                "keywords": [
                    "mRNA",
                    "新冠疫苗",
                    "复星",
                    "抵港",
                    "内地上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星mRNA新冠疫苗2月下旬抵港，内地上市正加速推进",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药行业重大事项点评：国务院发布药品带量采购意见 应采尽采 范围更广",
            "features": {
                "keywords": [
                    "国务院",
                    "药品带量采购",
                    "政策"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业重大事项点评：国务院发布药品带量采购意见 应采尽采 范围更广",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "复星医药(02196.HK)：2021年公司债(第一期)品种一票面利率为3.98%",
            "features": {
                "keywords": [
                    "复星医药",
                    "公司债",
                    "利率"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)：2021年公司债(第一期)品种一票面利率为3.98%",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中泰证券--医药生物行业周报：CRO/CDMO行情将如何延续？长坡厚雪，未来可期【行业研究】",
            "features": {
                "keywords": [
                    "中泰证券",
                    "CRO",
                    "CDMO",
                    "医药生物",
                    "行业研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰证券--医药生物行业周报：CRO/CDMO行情将如何延续？长坡厚雪，未来可期【行业研究】",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "郭广昌“猎A”新收获，一年内耗资近百亿 “复星系”版图再扩",
            "features": {
                "keywords": [
                    "郭广昌",
                    "猎A",
                    "复星系",
                    "收购"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "郭广昌“猎A”新收获，一年内耗资近百亿 “复星系”版图再扩",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "港交所辅助生殖基因检测第一股贝康医疗本周招股 超额认购已达78倍",
            "features": {
                "keywords": [
                    "港交所",
                    "贝康医疗",
                    "辅助生殖",
                    "基因检测",
                    "超额认购"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港交所辅助生殖基因检测第一股贝康医疗本周招股 超额认购已达78倍",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "《自然》子刊综述：乳腺癌的治疗现状与未来",
            "features": {
                "keywords": [
                    "自然",
                    "子刊",
                    "乳腺癌",
                    "治疗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "《自然》子刊综述：乳腺癌的治疗现状与未来",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "郭广昌27.6亿入主万盛股份 九个半月耗百亿收购三家A股公司",
            "features": {
                "keywords": [
                    "郭广昌",
                    "万盛股份",
                    "收购",
                    "A股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "郭广昌27.6亿入主万盛股份 九个半月耗百亿收购三家A股公司",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "郭广昌A股购物车又添新，揽入万盛股份即大涨，复星系32家全名单来了",
            "features": {
                "keywords": [
                    "郭广昌",
                    "A股",
                    "万盛股份",
                    "复星系"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "郭广昌A股购物车又添新，揽入万盛股份即大涨，复星系32家全名单来了",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]